Loading
Companies by trials sponsored
Companies ordered by how many trial records in the corpus link to them. Top 50 of 652 companies with a value; ties are broken by name. 3,743 of 6,143 trials link to at least one company record (61%).
602 more companies have a value below the top 50; the full list of companies is at /companies/.
How this is counted
Counts distinct trial records that name the company in their companies field or that the company's own trials field names. Sponsor names typed as free text on trials are not matched; only linked records count. The context column counts product records naming the company. Supportive care medicines (antiemetics, growth factors, epoetins, bone-modifying agents, antidotes, opioids for cancer pain, immunoglobulin; drug records flagged supportive) are not products or treatments here and are left out.
Coverage. 3,743 of 6,143 trials link to at least one company record (61%). Rows with a value of zero are not listed. Nothing is weighted, imputed or averaged; the ordering is by the number shown, then by name.
Machine-readable copy: /rankings/companies-by-trials/data.json. Registry: src/lib/rankings.ts.
Other rankings
- Cancers by number of trials
- Cancers by number of approved products
- Cancers with most trials per approved product
- Targets by number of products
- Targets by number of cancers
- Products by number of approval records
- Products by number of trials
- Products by years since first approval
- Companies by approval records
- People by listed papers
- Biomarker terms by number of cancers
- Trials by enrolment
- Roadmaps by number of eras